Old Drug Holds New Promise

Exciting new findings in UT's neurobiology labs suggest that rapamycin, an FDA-approved immunosuppressant used to control organ rejection in transplant patients, may be an effective therapy for Alzheimer's, epilepsy, and even autism. Now a UT team led by Professor Kim Raab-Graham of the College of Natural Sciences' Center for Learning and Memory is searching for an equivalent drug that can deliver the benefit without the side effects.